The IPO List
HomeListingsBlogsAboutJoin WhatsApp CommunityWhatsApp(Opens in a new tab)

The IPO List

Your trusted platform for IPO tracking and investment insights.

Quick Links

IPOsIPO ArchiveBlogsGMP AccuracyMethodologyAboutContact

Legal

Privacy PolicyTerms of ServiceDisclaimer

© 2026 The IPO List. All rights reserved.

  1. Home/
  2. IPO Calendar/
  3. Sudeep Pharma IPO
Sudeep Pharma
MainboardListed

Sudeep Pharma IPO

Bidding 21-25 Nov 2025, price band ₹563–593, lot 25 shares.

OverviewGMPAllotment

Grey Market Premium Trend

₹121
Final GMP
₹714
GMP-Implied Listing Price
20.4%
GMP-Implied Gain
₹563 - ₹593
Price Band

GMP History

DateGMP (₹)Est. Listing Price (₹)Est. Listing Gain
27 Nov₹121₹71420.40%
26 Nov₹121₹71420.40%
25 Nov₹97₹69016.36%
24 Nov₹86₹67914.50%
23 Nov₹90₹68315.18%
22 Nov₹121₹71420.40%
21 Nov₹113₹70619.06%
20 Nov₹115₹70819.39%
19 Nov₹122₹71520.57%
18 Nov₹130₹72321.92%
17 Nov₹93₹68615.68%
16 Nov₹0₹5930.00%

IPO timeline

  1. Issue open date
    21 Nov 2025
  2. Issue close date
    25 Nov 2025
  3. UPI mandate deadline
    25 Nov 2025
  4. Allotment finalization
    26 Nov 2025
  5. Refund initiation
    27 Nov 2025
  6. Share credit
    27 Nov 2025
  7. Listing date
    28 Nov 2025
  8. Mandate end date
    10 Dec 2025
  9. Lock-in end date for anchor investors (50%)
    26 Dec 2025
  10. Lock-in end date for anchor investors (remaining)
    24 Feb 2026

Sudeep Pharma IPO Allotment Status

Allotment date:26 Nov 2025
Registrar:MUFG Intime India Private Limited - Link Intime
  1. Open the registrar's allotment page from the link below.
  2. Select Sudeep Pharma from the list of companies.
  3. Enter your PAN, application number or demat account (DP/Client ID).
  4. Submit to see how many shares you were allotted.
Check allotment on MUFG Intime India(Opens in a new tab)BSE application status check(Opens in a new tab)

After allotment

Refund / mandate release:27 Nov 2025
Shares credited to demat:27 Nov 2025
Listing:28 Nov 2025

IPO Subscription Status

Total subscription:93.71x

Category-wise figures are not available right now.

Quick Stats

Issue Size:895cr
Lot Size:25 shares
Min Investment:₹14,825
P/E Ratio:47.61

About the Company

Sudeep Pharma is a technology-driven manufacturer of excipients and speciality ingredients for pharmaceutical, food, and nutrition industries. Since 1989, the company has expanded from basic excipients to over 100 products using in-house technologies for encapsulation, spray drying, granulation, and liposomal preparations. The company provides mineral-based ingredients (calcium, zinc, iron, potassium, magnesium) for pharmaceutical and food applications, while developing customized specialty ingredients including micronutrient premixes and encapsulated formulations through its subsidiary SNPL. Operating three manufacturing facilities in Vadodara, Gujarat with 65,579 metric tons capacity, Sudeep Pharma holds USFDA, WHO-GMP, and ISO approvals, serving over 1,100 customers globally including Pfizer, Merck Group, and Danone across 100 countries.

Strengths

  • Strong R&D drives innovation and product advancement.
  • Experienced leadership with deep industry and functional expertise.
  • Advanced, compliant facilities with global certifications and scalable capacity.
  • Long-standing relationships with global blue-chip and Fortune 500 customers.
  • Market leader with a diversified portfolio in a high-entry-barrier ingredients industry.

Risks

  • Top 10 customers contribute 35%+ of revenue, posing concentration risk.
  • 60%+ revenue from one segment poses concentration risk.
  • Quality lapses or audit failures may lead to order loss and reputational harm.
  • Operational concentration in Gujarat exposes the business to regional disruption risks.
  • Delays or failures in new product launches may impact growth and profitability.
  • Unsuccessful acquisitions may strain resources and dilute expected synergies.
  • Regulatory and government approval delays may disrupt operations.

Sudeep Pharma IPO – Frequently Asked Questions

  • The price band for the Sudeep Pharma IPO is set at ₹563 to ₹593 per share.
  • The Sudeep Pharma IPO opens on November 21, 2025 and closes on November 25, 2025.
  • The tentative listing date for the Sudeep Pharma IPO is November 28, 2025.
  • The last recorded Grey Market Premium (GMP) for the Sudeep Pharma IPO before listing was ₹121 (20.4%). GMP is unofficial and is not a guarantee of the listing price.
  • The Sudeep Pharma IPO allotment date is November 26, 2025. Once it is finalised, check your status with your PAN or application number on the website of the registrar, MUFG Intime India Private Limited - Link Intime. Issues listed on BSE can also be checked on the BSE application status page.
  • You can apply for the Sudeep Pharma IPO via your broker or bank using ASBA or UPI. Log in to your trading app (Zerodha, Upstox, Groww, etc.), select IPO section, choose Sudeep Pharma, enter lot quantity and UPI ID, then approve the mandate.
  • The lot size for the Sudeep Pharma IPO is 25 shares. Investors must apply for at least one lot (i.e., 25 shares), which costs ₹14,825 at the upper price band.

Related IPOs

Open and upcoming

  • Friends Union for Energising Lives (FUEL)Bidding 11-20 Nov 2026
    Open
  • Crystal Crop ProtectionBidding 18-20 Nov 2026
    Open
  • Mahanadi CoalfieldsBidding 19-23 Nov 2026
    Upcoming
  • Watrana RentalsBidding 19-23 Nov 2026
    Upcoming

Recent mainboard listings

  • Bombay Coated & Special SteelsListed 5 Nov 2026
    +10.98%
  • M.K.Sons Fine JewelsListed 4 Nov 2026
    +5.56%
  • BLS PolymersListed 3 Nov 2026
    +65.33%
  • SFC Environmental TechnologiesListed 3 Nov 2026
    +7.61%
  • EAAA India AlternativesListed 2 Nov 2026
    +0.63%
  • Jio PlatformsListed 28 Oct 2026
    +21.36%

All IPOs that opened in November 2025